Jon Hamilton

Jon Hamilton is a correspondent for NPR's Science Desk. Currently he focuses on neuroscience, health risks, and extreme weather.

Following the 2011 earthquake and tsunami in Japan, Hamilton was part of NPR's team of science reporters and editors who went to Japan to cover the crisis at the Fukushima Dai-ichi nuclear power plant.

Hamilton contributed several pieces to the Science Desk series "The Human Edge," which looked at what makes people the most versatile and powerful species on Earth. His reporting explained how humans use stories, how the highly evolved human brain is made from primitive parts, and what autism reveals about humans social brains.

In 2009, Hamilton received the Michael E. DeBakey Journalism Award for his piece on the neuroscience behind treating autism.

Before joining NPR in 1998, Hamilton was a media fellow with the Henry J. Kaiser Family Foundation studying health policy issues. He reported on states that have improved their Medicaid programs for the poor by enrolling beneficiaries in private HMOs.

From 1995-1997, Hamilton wrote on health and medical topics as a freelance writer, after having been a medical reporter for both The Commercial Appeal and Physician's Weekly.

Hamilton graduated with honors from Oberlin College in Ohio with a Bachelor of Arts degree in English. As a student, he was the editor of the Oberlin Review student newspaper. He earned his master's degree in journalism from Columbia University, where he graduated with honors During his time at Columbia, Hamilton was awarded the Baker Prize for magazine writing and earned a Sherwood traveling fellowship.

There's growing evidence that a physical injury to the brain can make people susceptible to post-traumatic stress disorder.

Studies of troops deployed to Iraq and Afghanistan have found that service members who suffer a concussion or mild traumatic brain injury are far more likely to develop PTSD, a condition that can cause flashbacks, nightmares and severe anxiety for years after a traumatic event.

A rare genetic disorder is helping scientists understand our mysterious ability to sense where we are in space, known as proprioception.

This "sixth sense" is what dancers and gymnasts rely on to tell them the exact position of their body and limbs at every moment. It also tells them how much force each muscle is exerting.

An experimental drug dramatically reduced the toxic plaques found in the brains of patients with Alzheimer's disease, a team reports in the journal Nature.

Results from a small number of patients who received a high dose of the drug, called aducanumab, hint that it may also be able to slow the loss of memory and thinking.

Forget Hawaii or Fiji. The spot that's really got surfers talking these days is a secluded pond more than 100 miles from the ocean, in California's Central Valley.

"It's just an amazing, amazing wave," says Robert "Wingnut" Weaver, a longboarder from Santa Cruz, Calif., and one of just a handful of surfers who have ridden the wave. "It's mind-blowing."

When tennis star Maria Sharapova admitted in March to having taken the heart drug meldonium, the public got a rare glimpse of a common practice that's often called "legal doping."

Pages